|
Britain's
Drug
Authority
Okays
Full-Scale
Patient
Cannabis
Trials
4/7/00
(courtesy NORML Foundation,
http://www.norml.org)
London, England:
Britain's Medicines Control Agency has given approval to GW Pharmaceuticals
for human medical marijuana trials.
This study is the first full-scale
patient trial of therapeutic cannabis products and will involve 2,000 patients.
Patients suffering from multiple sclerosis, spinal cord injury, severe
pain and spasticity will be involved in the trials.
"Our aim is to test some
of the claims which have been made for the medicinal qualities of cannabis
in a structured clinical research program," said Dr. Willy Notcutt who
leads this first trial. "This is an exciting moment, and we hope
very much that our findings will lead to significant improvements in the
pain relief available for sufferers of multiple sclerosis and other debilitating
conditions."
"It's remarkable that the
British government has moved so quickly on the matter of conducting actual
human trials with marijuana," said Allen St. Pierre, NORML Foundation Executive
Director. "The British have gone from white paper to parliamentary
report to research implementation in less than two years. Compare
that with the US, where, in the last 30 years the government has fought
'tooth and nail' to not allow medical access to marijuana."
-- END --
|
Issue #132, 4/7/00
AlertS: Colombia, New York State, HEA Reform | Penn State Student Government Endorses HEA Reform, Campaign Grows | CALIFORNIA: Santa Cruz Passes Ordinance Protecting Medical Marijuana Users | Another Zero-Tolerance Message Issued and Received | UK: Police Foundation Report Stirs Debate | Britain's Drug Authority Okays Full-Scale Patient Cannabis Trials | More "Propaganda for Dollars" Exposed by Dan Forbes and Salon.com, Salon Offering Drug War "Theme Park" on Web | LEGALIZACION: The L-Word Enters Post-Certification Debate in Mexico | NEWSBRIEF: US Anti-Drug Colonel Pleads Guilty | Follow-up to Sylvester Salcedo Interview | No Editorial This Week
|
This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
|
PERMISSION to reprint or
redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby
granted. We ask that any use of these materials include proper credit and,
where appropriate, a link to one or more of our web sites. If your
publication customarily pays for publication, DRCNet requests checks
payable to the organization. If your publication does not pay for
materials, you are free to use the materials gratis. In all cases, we
request notification for our records, including physical copies where
material has appeared in print. Contact: StoptheDrugWar.org: the Drug Reform Coordination Network,
P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202)
293-8344 (fax), e-mail [email protected]. Thank
you.
Articles of a purely
educational nature in Drug War Chronicle appear courtesy of the DRCNet
Foundation, unless otherwise noted.
|
